The prognostic value of BVAS and VDI in ANCA-AAV

The prognostic value of BVAS and VDI in ANCA-AAV

Detalhes bibliográficos
Main Authors:	Suppiah, R, Batra, R, Robson, J, Hoglund, P, Jayne, D, Westman, K, Luqmani, R
Formato:	Conference item
Publicado em:	2011

Registos relacionados

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Por: Suppiah, R, et al.
Publicado em: (2011)

Predicting cardiovascular events in patients with newly diagnosed ANCA-AAV
Por: Suppiah, R, et al.
Publicado em: (2011)

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials
Por: Luqmani, R, et al.
Publicado em: (2001)

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.
Por: Luqmani, R, et al.
Publicado em: (2000)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
Por: Robson, J, et al.
Publicado em: (2013)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
Por: Robson, J, et al.
Publicado em: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
Por: Robson, J, et al.
Publicado em: (2015)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
Por: Mukhtyar, C, et al.
Publicado em: (2008)

Outcome measures in ANCA-associated vasculitis.
Por: Suppiah, R, et al.
Publicado em: (2010)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
Por: Yew, S, et al.
Publicado em: (2012)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
Por: Luqmani, R, et al.
Publicado em: (2009)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
Por: Robson, J, et al.
Publicado em: (2013)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Por: Luqmani, R, et al.
Publicado em: (1994)

THE VASCULITIS DAMAGE INDEX (VDI)
Por: Exley, A, et al.
Publicado em: (1995)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
Por: Yew, S, et al.
Publicado em: (2012)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
Por: Basu, N, et al.
Publicado em: (2012)

Cardiovascular outcomes in ANCA associated vasculitis
Por: Mukhtyar, C, et al.
Publicado em: (2008)

Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV).
Por: Basu, N, et al.
Publicado em: (2012)

Modified Birmingham vasculitis activity score for Wegener's granulomatosis (BVAS/WG) - Construct validity.
Por: Maiden, N, et al.
Publicado em: (2000)

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire
Por: Robson, J, et al.
Publicado em: (2018)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Por: Suppiah, R, et al.
Publicado em: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
Por: Suppiah, R, et al.
Publicado em: (2011)

Long-term survival of ANCA-associated vasculitis
Por: Flossmann, O, et al.
Publicado em: (2009)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
Por: Suppiah, R, et al.
Publicado em: (2010)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Por: Mukhtyar, C, et al.
Publicado em: (2008)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
Por: Luqmani, R, et al.
Publicado em: (2017)

Classification criteria for the anca-associated vasculitides
Por: Robson, J, et al.
Publicado em: (2019)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
Por: McLaren, J, et al.
Publicado em: (2000)

Long-term patient survival in ANCA-associated vasculitis
Por: Flossmann, O, et al.
Publicado em: (2011)

Long-term patient survival in ANCA-associated vasculitis.
Por: Flossmann, O, et al.
Publicado em: (2011)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
Por: Luqmani, R, et al.
Publicado em: (2017)

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO
Por: Robson, J, et al.
Publicado em: (2017)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV
Por: Sara Monti, et al.
Publicado em: (2023-06-01)

SP0133 ANCA and their environment
Por: Luqmani, R
Publicado em: (2017)

Long-term patient survival in ANCA-associated vasculitis.
Por: Flossmann, O, et al.
Publicado em: (2011)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Por: Jones, R, et al.
Publicado em: (2010)

The role of rituximab in the treatment of ANCA-associated vasculitides (AAV)
Por: Thomas Daikeler, et al.
Publicado em: (2015-01-01)

A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).
Por: Luqmani, R, et al.
Publicado em: (1999)

Diagnosis and management of ANCA associated vasculitis.
Por: Berden, A, et al.
Publicado em: (2012)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
Por: Robson, J, et al.
Publicado em: (2013)